Determinants and Consequences of Personalized Health Care and Prevention (U01)

The summary for the Determinants and Consequences of Personalized Health Care and Prevention (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Determinants and Consequences of Personalized Health Care and Prevention (U01): This Funding Opportunity Announcement (FOA) solicits U01 applications for economic research on the determinants and consequences of personalization in health care and prevention. The objective of the research program is to support foundational research on economic aspects of individualized health interventions that will provide a framework for subsequent applied analyses. Program Director(s)/Principal investigator(s) for projects funded under this FOA are required to participate in a Steering Committee that will help identify key strategies to support critical research advances in this field. Research to be supported by this FOA includes analyses and development of research tools to advance understanding of: factors that affect the value of personalized interventions to individuals and their families, health care providers and payers, and society at large; incentives and constraints facing individuals and their families, health care providers, research organizations, drug and device manufacturers, and others and how they affect the actual and optimal extent to which interventions are tailored to patients personal characteristics or preferences; and strategies to promote improvements in health and cost outcomes through personalization of health care and preventive interventions. The purpose of this FOA is to expand generalizable understanding of the determinants and consequences of personalization in health care and prevention; it is not primarily intended to support evaluation of specific interventions or strategies for addressing particular health conditions.
Federal Grant Title: Determinants and Consequences of Personalized Health Care and Prevention (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-12-024
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.310
CFDA Descriptions: Trans-NIH Research Support
Current Application Deadline: Feb 28, 2013
Original Application Deadline: Feb 28, 2013
Posted Date: Nov 21, 2012
Creation Date: Nov 21, 2012
Archive Date: Mar 31, 2013
Total Program Funding: $2,700,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Resear...
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Resear...
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Open D...
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Ethic...
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
Using Metabolomics to Investigate Biological Pathways and Networks (R01)
Assay Development for High Throughput Molecular Screening (R21)
Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021 FederalGrants.com